Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-09-06 | 2017-10-03 | 21090 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-01-17 | 2018-02-06 | 36326 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-05-03 | 2024-05-31 | 227034 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-09-20 | 2025-02-21 | 238236 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-10-24 | 2025-02-21 | 241069 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-12-05 | 2025-02-14 | 244896 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-02 | 2023-02-23 | 183492 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184106 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-02 | 2023-04-27 | 185936 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-07-31 | 2019-08-19 | 90350 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-28 | 2019-12-20 | 92525 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-09-04 | 2019-11-21 | 92989 |
| APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-03 | 2022-02-14 | 150435 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-21 | 2022-03-14 | 153282 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-28 | 2022-03-24 | 153786 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2021-04-16 | 2021-04-26 | 137592 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2021-10-22 | 2021-10-29 | 147821 |
| APO-PAROXETINE | 20MG | TABLET | Resolved | 2017-11-13 | 2018-04-06 | 29039 |
| APO-PAROXETINE | 10MG | TABLET | Resolved | 2017-11-28 | 2018-03-05 | 30954 |
| APO-PAROXETINE | 30MG | TABLET | Resolved | 2017-12-06 | 2018-03-08 | 31910 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |